Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)
South Korea · Delayed Price · Currency is KRW 25,750
+850 (3.41%)
Last updated: Nov 26, 2025, 9:00 AM KST
KRX:019175 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 231,902 | 221,094 | 200,229 | 209,288 | 189,237 | 197,751 | Upgrade |
Other Revenue | -0 | - | - | -0 | - | - | Upgrade |
| 231,902 | 221,094 | 200,229 | 209,288 | 189,237 | 197,751 | Upgrade | |
Revenue Growth (YoY) | 7.64% | 10.42% | -4.33% | 10.60% | -4.30% | 4.23% | Upgrade |
Cost of Revenue | 134,855 | 139,290 | 119,951 | 131,315 | 111,850 | 121,224 | Upgrade |
Gross Profit | 97,047 | 81,804 | 80,277 | 77,973 | 77,388 | 76,527 | Upgrade |
Selling, General & Admin | 78,916 | 77,764 | 79,068 | 76,549 | 69,256 | 59,480 | Upgrade |
Research & Development | 14,578 | 17,879 | 42,277 | 30,383 | 17,334 | 5,622 | Upgrade |
Amortization of Goodwill & Intangibles | 579.58 | 969.42 | 1,182 | 1,358 | 1,496 | 1,348 | Upgrade |
Other Operating Expenses | 768.16 | 800.65 | 394.37 | 646.98 | 3,241 | 778.8 | Upgrade |
Operating Expenses | 98,778 | 98,833 | 127,670 | 111,992 | 91,694 | 68,782 | Upgrade |
Operating Income | -1,731 | -17,029 | -47,392 | -34,019 | -14,306 | 7,746 | Upgrade |
Interest Expense | -2,702 | -2,632 | -1,719 | -61.42 | -202.06 | -2,945 | Upgrade |
Interest & Investment Income | 762.47 | 704.06 | 1,174 | 1,026 | 1,878 | 1,946 | Upgrade |
Earnings From Equity Investments | - | - | -6,514 | -697.09 | 2,620 | 2,520 | Upgrade |
Currency Exchange Gain (Loss) | 687.4 | 2,833 | 1,328 | -1,009 | 406.81 | -1,128 | Upgrade |
Other Non Operating Income (Expenses) | -248.57 | 279.23 | 653.36 | -182.48 | 314.91 | -415.97 | Upgrade |
EBT Excluding Unusual Items | -3,232 | -15,844 | -52,471 | -34,942 | -9,288 | 7,724 | Upgrade |
Gain (Loss) on Sale of Investments | 1,343 | 1,215 | -1,011 | 845.62 | 253.64 | -868.38 | Upgrade |
Gain (Loss) on Sale of Assets | 2.09 | 6.89 | 39.65 | 18.31 | 49.02 | -29.96 | Upgrade |
Asset Writedown | - | - | - | -703.23 | - | - | Upgrade |
Pretax Income | -1,886 | -14,622 | -53,442 | -34,782 | -8,986 | 8,340 | Upgrade |
Income Tax Expense | 2,869 | 751.41 | 3,831 | 527.29 | 2,540 | 3,294 | Upgrade |
Earnings From Continuing Operations | -4,755 | -15,373 | -57,273 | -35,309 | -11,526 | 5,046 | Upgrade |
Minority Interest in Earnings | 480.33 | -13.8 | -52.86 | -68.14 | -57.61 | -42.93 | Upgrade |
Net Income | -4,275 | -15,387 | -57,325 | -35,377 | -11,584 | 5,003 | Upgrade |
Preferred Dividends & Other Adjustments | -566.67 | -566.67 | - | - | - | - | Upgrade |
Net Income to Common | -3,708 | -14,821 | -57,325 | -35,377 | -11,584 | 5,003 | Upgrade |
Net Income Growth | - | - | - | - | - | -6.03% | Upgrade |
Shares Outstanding (Basic) | 50 | 51 | 51 | 51 | 51 | 50 | Upgrade |
Shares Outstanding (Diluted) | 50 | 51 | 51 | 51 | 51 | 50 | Upgrade |
Shares Change (YoY) | -4.50% | - | - | - | 1.85% | 0.71% | Upgrade |
EPS (Basic) | -74.01 | -289.11 | -1118.28 | -690.12 | -225.97 | 99.40 | Upgrade |
EPS (Diluted) | -74.01 | -289.11 | -1118.28 | -690.12 | -225.97 | 99.40 | Upgrade |
EPS Growth | - | - | - | - | - | -2.22% | Upgrade |
Free Cash Flow | -6,692 | -20,724 | -39,696 | -31,767 | -75,453 | 17,408 | Upgrade |
Free Cash Flow Per Share | -133.57 | -404.27 | -774.37 | -619.69 | -1471.90 | 345.89 | Upgrade |
Dividend Per Share | - | - | - | - | - | 100.000 | Upgrade |
Gross Margin | 41.85% | 37.00% | 40.09% | 37.26% | 40.89% | 38.70% | Upgrade |
Operating Margin | -0.75% | -7.70% | -23.67% | -16.25% | -7.56% | 3.92% | Upgrade |
Profit Margin | -1.60% | -6.70% | -28.63% | -16.90% | -6.12% | 2.53% | Upgrade |
Free Cash Flow Margin | -2.89% | -9.37% | -19.82% | -15.18% | -39.87% | 8.80% | Upgrade |
EBITDA | 9,885 | -5,066 | -35,484 | -21,215 | -1,631 | 19,954 | Upgrade |
EBITDA Margin | 4.26% | -2.29% | -17.72% | -10.14% | -0.86% | 10.09% | Upgrade |
D&A For EBITDA | 11,616 | 11,963 | 11,908 | 12,803 | 12,675 | 12,208 | Upgrade |
EBIT | -1,731 | -17,029 | -47,392 | -34,019 | -14,306 | 7,746 | Upgrade |
EBIT Margin | -0.75% | -7.70% | -23.67% | -16.25% | -7.56% | 3.92% | Upgrade |
Effective Tax Rate | - | - | - | - | - | 39.50% | Upgrade |
Advertising Expenses | - | 16,981 | 17,979 | 19,126 | 17,097 | 15,574 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.